A Study of LY2801653 in Healthy Participants Who Are Not Able to Have Children
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate how much of the LY2801653 drug is available in the
body when given in 2 different formulations with and without a meal to healthy participants
who are not able to have children. In addition, this study will measure how much of the drug
gets into the blood stream and how long it takes the body to get rid of it. Information about
any side effects that may occur will also be collected. The study will last about 27 days.
Screening is required within 28 days prior to the start of the study.